Tikun Olam-Cannbit Pharmaceuticals Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Yifat Karib
Chief executive officer
₪674.0k
Total compensation
| CEO salary percentage | 86.4% |
| CEO tenure | 3.9yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Apr 28
Risks To Shareholder Returns Are Elevated At These Prices For Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)
Jul 21Would Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Be Better Off With Less Debt?
Oct 03Is Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Weighed On By Its Debt Load?
Jun 03Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Is Carrying A Fair Bit Of Debt
Oct 17Is Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Using Debt Sensibly?
May 19Shareholders Of Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Must Be Happy With Their 135% Total Return
Mar 19How Much Did Tikun Olam - Cannbit Pharmaceuticals'(TLV:TKUN) Shareholders Earn From Share Price Movements Over The Last Five Years?
Dec 02
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -₪89m |
| Sep 30 2023 | n/a | n/a | -₪98m |
| Jun 30 2023 | n/a | n/a | -₪107m |
| Mar 31 2023 | n/a | n/a | -₪77m |
| Dec 31 2022 | ₪674k | ₪582k | -₪48m |
| Sep 30 2022 | n/a | n/a | -₪38m |
| Jun 30 2022 | n/a | n/a | -₪27m |
| Mar 31 2022 | n/a | n/a | -₪30m |
| Dec 31 2021 | ₪850k | ₪565k | -₪33m |
Compensation vs Market: Yifat's total compensation ($USD179.59K) is below average for companies of similar size in the IL market ($USD434.82K).
Compensation vs Earnings: Yifat's compensation has been consistent with company performance over the past year.
CEO
Yifat Karib (50 yo)
3.9yrs
Tenure
₪674,000
Compensation
Ms. Yifat Karib is CEO from March 27, 2023, VP of Marketing & Government Relations from June 01, 2020 at Tikun Olam-Cannbit Pharmaceuticals Ltd respectively.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Director | 4.9yrs | no data | 2.7% ₪ 866.0k | |
| Chairman of the Board | 4.9yrs | ₪505.00k | no data | |
| Director | 4.9yrs | no data | 10.51% ₪ 3.4m | |
| Independent Director | 4.6yrs | no data | 0.060% ₪ 19.3k | |
| Independent External Director | 3.2yrs | no data | no data | |
| Independent External Director | 2.8yrs | no data | no data |
4.8yrs
Average Tenure
58.5yo
Average Age
Experienced Board: TKUN's board of directors are considered experienced (4.8 years average tenure).